Association Between Renal Adverse Effects and Mortality in Patients With Hepatocellular Carcinoma Treated With Lenvatinib.
In Vivo
; 35(3): 1647-1653, 2021.
Article
in En
| MEDLINE
| ID: mdl-33910848
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Liver Neoplasms
/
Antineoplastic Agents
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
Country/Region as subject:
Asia
Language:
En
Journal:
In Vivo
Journal subject:
NEOPLASIAS
Year:
2021
Document type:
Article
Country of publication: